BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Lonza Launches TheraPEAK® T-VIVO® Cell Culture Medium to Accelerate Cell Therapy Development

Lonza launches the TheraPEAK® T-VIVO® Cell Culture Medium with a novel chemically defined formulation developed to optimize and streamlin...

May 16, 2023 | News

Malaysian Genomics Inks Agreement in Expansion to Bangladesh

Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, today announced a strategic coope...

May 16, 2023 | News

MGI Enables Completion of 60,000 Samples for Million Microbiome of Humans Project

The project was launched as a joint effort by the Karolinska Institute of Sweden, Shanghai National Clinical Research Center for Metabolic D...

May 16, 2023 | News

Rona Therapeutics and Keymed Biosciences Collaborate on siRNA Therapeutics for Glomerulonephritis

Under the term of the collaboration, Rona will use proprietary RAZOR™ platform to discover and identify siRNA lead compounds directed to a novel targ...

May 16, 2023 | News

Innovent's IBI351 gets NMPA breakthrough designation for advanced colorectal carcinoma

This BTD for IBI351 was based on the pooled analysis of two ongoing clinical trials (NCT05005234, NCT05497336), which include 54 CRC pa...

May 15, 2023 | News

LaNova licenses novel cancer drug to AstraZeneca

LaNova Medicines Ltd. ("LaNova Medicines") announced it has entered into an exclusive license agreement with AstraZeneca (LSE/STO/Nasdaq: AZN), for LM-305,...

May 15, 2023 | News

Microba Partners with Mainz Biomed for the Development of PancAlert

Combination of DNA biomarkers with microbiome biomarkers has potential to enhance technical profile of novel pancreatic cancer screening test Joint rese...

May 12, 2023 | News

SHL Medical and MoonLake Immunotherapeutics collaborate to develop sonelokimab autoinjector

Sonelokimab is MoonLake Immunotherapeutics' investigational anti-IL-17 A/F Nanobody technology designed to more directly target sites of inflammation and p...

May 11, 2023 | News

China's Guangzhou hosts Golden Age Single-Cell and Spatial Omics Conference

The conference brings together on site over 2,000 professionals from academia, research and development, investment and other fields interested to the conf...

May 09, 2023 | News

Hummingbird Bioscience to showcase preclinical proof of concept for novel autoimmune disease antibody

HMBD-011 is a potentially first-in-class anti-VH4-34 antibody developed for treatment of VH4-34+ antibody-driven pathogenesis in lupus and cold agglutini...

May 09, 2023 | News

Neuro3 Therapeutics obtains global rights for KCNQ2 activators from Lundbeck

The agreement focuses on activators of KCNQ2, an ion channel that has been clinically validated as a target for the treatment of epilepsy. Clinical findin...

May 09, 2023 | Opinion

Singapore Approves New Therapy for Rare Gastrointestinal Stromal Tumors

Singapore's Health Sciences Authority (HSA) has approved QINLOCK® (ripretinib) for the treatment of patients with 4th line GIST QINLO...

May 08, 2023 | News

Cambridge Infinitus Research Centre Launches AI-based ERnet Platform for Cellular Health Studies.

With an impact factor of 47.99, Nature Methods is the world's leading international publication for biochemical research methodology. Upon public...

May 05, 2023 | News

ABM Initiates Phase I Clinical Trial of MEK Inhibitor for Solid Tumor, Doses First Patient

MEK (mitogen-activated protein kinase kinase), a key kinase of the MAPK pathway, is frequently activated in various cancers, including those with RAS mutat...

May 05, 2023 | News

Stay Connected